LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 58.15 | 27.76 | 1187 | 5906 | 0.2010 | 0.6252 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 59.85 | 27.76 | 1071 | 6062 | 0.1767 | 0.6001 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 59.85 | 27.76 | 1109 | 6062 | 0.1829 | 0.6073 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 59.85 | 27.76 | 158 | 6062 | 0.0261 | 0.2508 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 59.85 | 27.76 | 1165 | 6062 | 0.1922 | 0.6175 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 61.56 | 27.76 | 1057 | 6217 | 0.1700 | 0.5939 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 61.56 | 27.76 | 1113 | 6217 | 0.1790 | 0.6045 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 61.56 | 27.76 | 168 | 6217 | 0.0270 | 0.2594 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 61.56 | 27.76 | 1115 | 6217 | 0.1793 | 0.6049 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 63.26 | 27.76 | 907 | 6465 | 0.1403 | 0.5580 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 63.26 | 27.76 | 1062 | 6465 | 0.1643 | 0.5895 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 63.26 | 27.76 | 169 | 6465 | 0.0261 | 0.2582 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 63.26 | 27.76 | 1079 | 6465 | 0.1669 | 0.5928 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 64.97 | 27.76 | 785 | 6656 | 0.1179 | 0.5262 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 64.97 | 27.76 | 1106 | 6656 | 0.1662 | 0.5938 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 64.97 | 27.76 | 176 | 6656 | 0.0264 | 0.2632 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 64.97 | 27.76 | 1211 | 6656 | 0.1819 | 0.6122 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 66.67 | 27.76 | 448 | 6695 | 0.0669 | 0.4211 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 66.67 | 27.76 | 1096 | 6695 | 0.1637 | 0.5912 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 66.67 | 27.76 | 183 | 6695 | 0.0273 | 0.2691 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 66.67 | 27.76 | 1224 | 6695 | 0.1828 | 0.6135 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 68.37 | 27.76 | 253 | 6879 | 0.0368 | 0.3203 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 68.37 | 27.76 | 1099 | 6879 | 0.1598 | 0.5881 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 68.37 | 27.76 | 188 | 6879 | 0.0273 | 0.2719 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 68.37 | 27.76 | 1131 | 6879 | 0.1644 | 0.5938 | MN20160318_Q01 | L13 |